Healthcare Media Decision Sprint
For lean emerging biotech and healthcare teams facing one launch or budget decision. One brand. One market. One decision.
- Timing
- A clear media recommendation in a focused, ten-business-day sprint. Timeline confirmed after reviewing your scope and inputs. Start date depends on Michelle’s availability. Missing inputs, delayed feedback, or a changed question may require a revised timeline.
- Bring
- A decision question and deadline, one decision owner, budget boundaries, audience priorities, an existing plan if available, and permitted evidence. Include available measurement and reporting constraints. Start the inquiry with category-level detail only.
- Commercial terms
- A fixed project fee quoted after a fit review. Written scope and fee are agreed before work begins.
Five concrete outputs
- Reconciled inputs. Definitions, conflicts, missing evidence, and assumptions in one place.
- Three scenarios. Comparable options with trade-offs and explicit uncertainty.
- An editable workbook. Inputs, calculations, and scenario assumptions your team can update.
- An evidence ledger. Source, date, permission, confidence, and caveat for each material input.
- A reviewed recommendation. Audience priorities, channel roles, investment allocation, and a measurement plan: what to track, who owns it, and when to review. Michelle Humes Perkins explains the trade-offs, evidence gaps, and conditions for changing course.
Includes one kickoff, one recommendation discussion, and one consolidated revision within the agreed decision. Proposed sequence: days 1–2 align inputs; days 3–7 develop evidence and scenarios; days 8–10 cover the recommendation and revision. The schedule is agreed at kickoff. One decision owner coordinates feedback within two business days.
AI accelerates research organization and scenario drafting. Michelle checks sources, challenges assumptions, and owns the recommendation. The value is her judgment, not an automated answer.
HCP and patient/consumer (HCC) planning are included where relevant. Primary research, purchased or licensed data, media buying, activation, creative production, legal or MLR approval, and ongoing optimization are excluded. Additional brands, markets, decisions, or revisions require a separate scope. The Sprint provides a recommendation, not a performance guarantee.
Inspect a synthetic example